In the realm of pharmacovigilance and drug safety, comprehensive documentation is essential for ensuring the safety and efficacy of medicinal products. One critical aspect of this documentation is the “18 II Listedness Expectedness Assessment Reference Safety Information Documents” (LEARSID). This article aims to provide an in-depth understanding of these documents, their purpose, structure, and significance … Continue reading 18 II Listedness Expectedness Assessment Reference Safety Information Documents